Delivery Order SPE2DB22D2007-SPE2DB25FJ4CM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,365.40 to AmerisourceBergen Drug Corp for Fentanyl 100 mcg/2 mL vials on July 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The order is scheduled for completion by July 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 MCG/2 ML Vial 2ML, valued at $1,667.43. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This contract represents a child order under...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,689 firm-fixed-price delivery order covers the supply of 4,563,303,395 units of the drug Fentanyl 100 mcg/2 ml vial. The award has an ultimate completion date of January 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,209.71, is for the delivery of 4,568,051,227 units of Fentanyl Citrate 20 mL 25s, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 29, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,168.51, is for the supply of 4563927584 Fentanyl 100 MCG/2 ML vials. The contract is a Firm Fixed Price arrangement and has a completion date of March 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fentanyl 100 MCG/2 ML vials. The contract has a firm fixed price of $2,012.06 and a period of performance extending to July 14, 2025. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,258.56, is for the delivery of Fentanyl 100 mcg/2 mL vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,571.37 firm fixed price contract is for the delivery of 4,565,218,749 units of 100 mcg/2 mL Fentanyl vials. The contract has a completion date of July 23, 2024 and was awarded on July 22, 2024. This order is not set aside for any small business program. Amerisourcebergen is a major pharmaceutical distributor that holds several...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of fentanyl 100 mcg/2 ml vials, with a ceiling value of $2,236.90 and a period of performance through June 13, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the contract is a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,342.96, is for the delivery of Fentanyl 50 MCG/ML vials to support federal government medical requirements. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4CMDelivery Order
This delivery order, issued on August 19, 2025, awards AmerisourceBergen Drug Corp $1,721.36 to supply Fentanyl 100 micrograms per 2 milliliter vials for the Defense Logistics Agency (DLA). The contract is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical vendor that provides an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. The company holds a significant position within the DLA's Medical Supply Chain and regularly fulfills delivery orders for specialized pharmaceutical products across multiple therapeutic domains. This fentanyl procurement reflects the ongoing demand for pain management pharmaceuticals within the federal healthcare system and demonstrates the company's capability to meet urgent medical supply requirements through its established prime vendor contract with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/19/25 |